[1]
2025. Determining the directions for developing a methodology for comprehensive assessment of ESG activity in China’s biopharmaceutical territorial-sectoral complexes. Modern Economics: Problems and Solutions. 12, (Dec. 2025), 61–74. DOI:https://doi.org/10.17308/meps/2078-9017/2025/12/61-74.